Skip to main content
Clinical Trials/JPRN-jRCT1031210446
JPRN-jRCT1031210446
Recruiting
未知

Study on the efficacy and safety of Remimazolam in one lung ventilation. - SEREV study

Hirotsugu Okamoto0 sites70 target enrollmentNovember 24, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Hirotsugu Okamoto
Enrollment
70
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 24, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hirotsugu Okamoto

Eligibility Criteria

Inclusion Criteria

  • Patients aged 20 years and older undergoing lung surgery with one\-lung ventilation and general anesthesia with epidural

Exclusion Criteria

  • If the research subject refuses to cooperate in the research.
  • Contraindications to the use of anesthetics.
  • If the subject has a disease that affects HPV.
  • In the case of a procedure in which one lung ventilation is frequently released intraoperatively, such as surgery for pneumothorax.
  • Patients with longitudinal tumors in the supine position who may require only short periods of one\-lung ventilation.
  • If the patient is scheduled to receive intraoperative cardiopulmonary ventilation.
  • Patients with severe chronic lung disease (1 sec rate 50%or less, % lung capacity less than 80%)

Outcomes

Primary Outcomes

Not specified

Similar Trials